Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0060 (7.41%)
Nov 11, 2026, 4:10 PM AEDT
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 44.66 million as of November 10, 2026. It is the 33,991st most valuable company in the world and the 825th biggest in Australia. Its market cap has decreased by 33.05% in one year.
Market Cap
44.66M
Enterprise Value
17.15M
Revenue
4.79M
Global Rank
Country Rank
#825 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 44.66M, an increase of 29.46%. That is a compound annual growth rate of 2.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 44.66M | -41.97% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 86.58M |
| Prescient Therapeutics | 72.06M |
| Arovella Therapeutics | 61.65M |
| Alterity Therapeutics | 60.71M |
| Entropy Neurodynamics | 47.37M |
| Avecho Biotechnology | 46.36M |
| Neurizon Therapeutics | 44.96M |
| Immutep | 36.84M |